Ziprasidone

Also known as: Geodon, Zeldox, CP-88059, CP-88059-1, Ziprasidone HBr, Zipwell, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one, 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, 5-{2-[4-(1,2-benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, 5-{2-4-(1,2-benzothiazol-3-yl)piperazin-1-ylethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, ziprasidona, ziprasidonum

Ziprasidone (CAS 146939-27-7) is a compound in the Ketones category listed in the Jingsj chemical database. It has the molecular formula C21H21ClN4OS and a molecular weight of 412.94 g/mol. Key properties include a melting point of 213-215°C, a boiling point of 554.8±50.0 °C at 760 mmHg, a density of 1.4±0.1 g/cm3 and a flash point of 289.3±30.1 °C. It is classified under GHS with signal word Danger and hazard statements H225 — Highly flammable liquid and vapour and H315 — Causes skin irritation. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 146939-27-7
Jingsj CID: J-45108-8
Molecular Formula: C₂₁H₂₁ClN₄OS
Molecular Weight: 412.94 g/mol
Category: Ketones
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	213-215°C
Boiling Point	554.8±50.0 °C at 760 mmHg
Density	1.4±0.1 g/cm3
Flash Point	289.3±30.1 °C
PSA	76.71000
LogP	4.00
Vapor Pressure	0.0±1.5 mmHg at 25°C
Refractive Index	1.681
Storage Conditions	Refrigerator

GHS Safety & Compliance

Flammable / Irritant / Health HazardSignal word: Danger

H225 — Highly flammable liquid and vapour
H315 — Causes skin irritation

Activity & Biological Data

Additional Information	[1]. Seeger, T.F., et al., Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther, 1995. 275(1): p. 101-13. [2]. Prakash, C., et al., Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Drug Metab Dispos, 1997. 25(7): p. 863-72. [3]. Gao, K., et al., Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia. J Clin Psychopharmacol, 2013. 33(3): p. 425-31.

Additional Information

[1]. Seeger, T.F., et al., Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther, 1995. 275(1): p. 101-13. [2]. Prakash, C., et al., Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Drug Metab Dispos, 1997. 25(7): p. 863-72. [3]. Gao, K., et al., Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia. J Clin Psychopharmacol, 2013. 33(3): p. 425-31.

Customs & Trade Information

HS Code	29211980

Frequently Asked Questions

What is the CAS number of Ziprasidone?

The CAS number of Ziprasidone is 146939-27-7.

What are the molecular formula and molecular weight of Ziprasidone?

Ziprasidone has molecular formula C21H21ClN4OS and molecular weight 412.94 g/mol.

Is Ziprasidone hazardous?

Ziprasidone has GHS signal word Danger and hazard statements H225 — Highly flammable liquid and vapour; H315 — Causes skin irritation.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Ziprasidone (CAS 146939-27-7)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-45108-8 (accessed 2026-11-06).

Data for reference only; verify product details with suppliers before purchase.